Milton Essex Spolka Akcyjna Logo

Milton Essex Spolka Akcyjna

Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.

MTN | WAR

Overview

Corporate Details

ISIN(s):
PLMLTNE00013
LEI:
259400QAFDSRLAIDCH26
Country:
Poland
Address:
WARSZAWA ŻOŁNY 42A, 02-815 WARSZAWA
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Milton Essex S.A. is a medical technology company specializing in the development of innovative diagnostic systems that integrate artificial intelligence (AI), optoelectronics, and thermodynamics. The company's core focus is on revolutionizing allergy diagnostics and personalized medicine. Its flagship product, SkinSENS™, offers an automated, non-invasive method for diagnosing skin allergic reactions using hyperspectral imaging. Milton Essex is also expanding into biotechnology and develops other solutions, including the ActiveSCAN™ biometric system and multispectral skin imaging technologies. The company actively engages in research and development, leveraging technology transfer from partnerships, including the military sector, to advance its medical applications and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-01 22:34
Declaration of Voting Results & Voting Rights Announcements
: Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajn…
Polish 1.4 KB
2024-03-28 12:44
Post-Annual General Meeting Information
projekty uchwał na NWZA Spółki w dniu 23 kwietnia 2024
Polish 144.8 KB
2024-03-28 12:44
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Milton Essex S.A. na …
Polish 653 bytes
2023-09-11 12:50
Investor Presentation
Strategia komercjalizacji Palety Produktowej Med-Tech System SkinSENS(tm) na la…
Polish 574.5 KB
2023-09-11 12:50
Report Publication Announcement
: Przyjęcie strategii komercjalizacji Systemu SkinSENS - Content (PL)
Polish 1.7 KB
2023-08-30 11:04
Registration Form
Decyzja Europejskiego Urzędu Patentowego o udzieleniu patentu Spółce - Content …
Polish 2.6 KB
2023-06-28 12:05
Major Shareholding Notification
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 1.5 KB
2023-05-31 17:25
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu ZWZA MIlton Essex SA wraz z projektami uchwał
Polish 511.0 KB
2023-05-31 17:25
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Milton Essex S.A. na dzi…
Polish 719 bytes
2023-05-25 12:58
Regulatory News Service
Kolejny etap procesu certyfikacji produktu SkinSens- Imaging System for in vivo…
Polish 2.2 KB
2023-05-15 18:04
Regulatory News Service
uzyskanie patentu przez Spółkę w Europejskim Urzędzie Patentowym - Content (PL)
Polish 2.6 KB
2023-05-11 16:05
Regulatory News Service
podpisanie umowy licencyjnej z ZURAD SP. z o.o. - Content (PL)
Polish 1.6 KB
2023-02-07 19:15
Regulatory News Service
uzyskanie patentu przez Spółkę w Japonii - Content (PL)
Polish 1.6 KB
2022-12-13 23:56
Regulatory News Service
: uzyskanie możliwości rozpoczęcia badań klinicznych SkinSense - Content (PL)
Polish 1.9 KB
2022-11-10 12:23
Declaration of Voting Results & Voting Rights Announcements
wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajny…
Polish 1.4 KB

Automate Your Workflow. Get a real-time feed of all Milton Essex Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Milton Essex Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.